Ukraine to force pharmaceutical firms to discontinue Russian activities
The war-torn country wants to pressure companies into making a choice: Exit Russia or lose market licenses in Ukraine.
by astrid sturlarson, translated by daniel pedersen
Novo Nordisk is still producing insulin for the Russian market, though the company has ceased marketing drugs in the country.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Coloplast will not exit Russia, says CEO
For subscribers
Western medtech exports to Russia pick up speed again
For subscribers
